English | Español

Regulatory
+ Regulatory
Robert Hadley | Nov 8, 2017

Europe agency approves expanded use of Bristol-Myers Squibb’s Opdivo to treat advanced melanoma
+ Community
Robert Hadley | Nov 7, 2017

Flu more likely to send people in poverty to hospital, Vanderbilt study says
+ Technology/Innovation
Robert Hadley | Nov 7, 2017

FDA fast-tracking review for AbbVie’s endometriosis drug
+ Community
John Breslin | Nov 7, 2017

Merger of Parkinson's support groups will better serve patients, chief executive says
+ Technology/Innovation
Mark Iandolo | Nov 3, 2017

Wake Forest Baptist Medical Center details treatment options for migraine sufferers
+ Community
Mark Iandolo | Nov 3, 2017

Community events slated for people with autoimmune liver disease
+ Community
Carol Ostrow | Nov 3, 2017

NIH grants to fund studies focusing on ethics in brain research
+ Community
Mark Iandolo | Nov 3, 2017

Stony Brook University Medical Center to hold neuroscience symposium

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'